According to a new study, women are switching away from tech majors during college at a higher rate than any other areas of study, and it comes down to culture. Photo via Getty Images

Like anyone pursuing a technical career, I had to overcome certain hurdles on my way to graduating with a degree in aerospace engineering. When one of my professors suggested that women should not be engineers and I would be better served pursuing a career like nursing or teaching, I realized that my hurdles might be a little different than others.

Luckily, I was raised to view this as a challenge and opportunity rather than an insurmountable obstacle.

Unfortunately, not everyone maintains my positive outlook on situations like this, and too often, young women are ultimately dissuaded from pursuing engineering and other similar technical degrees.

In fact, according to the research by Accenture and Girls Who Code, women are switching away from tech majors during college at a higher rate than any other areas of study. What's more, 50 percent of women pursuing a career in technology after graduation change paths by age 35, compared to 20 percent in other jobs. Female workers also leave tech jobs at a 45 percent higher rate than men.

Even more alarming, the same study found that in the last 35 years, the proportion of women in tech careers has actually declined despite the increase in the absolute number of female technology workers.

What's going on? Our research shows women in tech often don't feel at home or comfortable during college or at the workplace.

While there are many reasons women abandon a career in technology, the highest percentage of respondents cite culture as the leading cause. Although 45 percent of senior human resources leaders say that it is easy for women to thrive in tech, only 21 percent of women agree, and that number falls to just 8 percent for women of color. Conversely, women in college who find themselves in inclusive learning environments tend to enjoy their majors, network more and are more likely to stay in their STEM degrees.

The current labor market is struggling to keep pace with the explosive demand for tech talent, and I can attest — having met many of these amazing ladies — that women are willing, able and ready to help meet this demand.

Here are some ideas to create a culture that encourages more women to stay with STEM degrees and thrive in technology careers.

In college, having strong mentoring programs for female students in technology is key. Being part of study groups and student organizations, like the Society of Women Engineers, encourages learning and teaming and drives collaboration, innovation and inclusion. Based on our analysis, inclusive colleges are those that have at least 35 percent women in their STEM faculty. Publicizing faculty and student diversity data is a courageous way for colleges to ensure accountability and show their commitment to a culture of equality.

In business, we all know that what's measured gets managed. Applying this principle, it's both bold and important for companies to set targets for diversity in the leadership teams and publish those goals, as well as create clear KPIs governing compensation to the accountable leaders.

Furthermore, workplace support such as mentors, sponsors and employee resource networks can go a long way in creating the right culture and boost women in tech. Remember that many women enter tech careers because they want to make a difference in the world. Fostering collaborative environments where workers are rewarded for creativity and innovation does much more than — but certainly helps — to retain women.

Organizations that have diverse talent and a welcoming culture of equality help enable success and unleash human ingenuity. Rewarding excellence with the right innovative, supportive culture is a winning philosophy not only for women but for companies overall.

------

Sondra Ruhman is a Houston-based managing director at Accenture Operations. She helps North American and Global clients embark on major technology and operational transformation projects.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.